Incidence of respiratory syncytial virus bronchiolitis in hospitalized infants born at 33-36 weeks of gestational age compared with those born at term: a retrospective cohort study
- PMID: 31181285
- DOI: 10.1016/j.cmi.2019.05.025
Incidence of respiratory syncytial virus bronchiolitis in hospitalized infants born at 33-36 weeks of gestational age compared with those born at term: a retrospective cohort study
Abstract
Objective: The aim was to compare incidences of respiratory syncytial virus (RSV) bronchiolitis in late preterm vs. term infants (33-36 vs. >36 weeks of gestational age (WGA)).
Methods: This was a population-based retrospective study including all infants <12 months hospitalized at Soroka medical centre with bronchiolitis between 2004 and 2012. Infants with comorbidities were excluded. RSV bronchiolitis rates were calculated by extrapolating the proportion of positive tests among tested infants. Population denominator for incidence rates was calculated from hospital records.
Results: During the study, 374 late preterm and 2948 term infants were hospitalized with bronchiolitis. Out of 229 (61.2%) late preterm infants and 1738 (59%) term infants tested for RSV, 164 (71.6%) and 1266 (72.8%) were positive for RSV respectively. The mean yearly incidences per 1000 children of RSV bronchiolitis hospitalizations of late preterm and term infants were 35.8 ± 13.0 and 19.6 ± 4.1 respectively (p 0.009). During RSV seasons the mean incidence rate ratio between groups was 1.82 (95% CI 1.60-2.08). Duration of hospitalization was 4.8 ± 7.0 and 3.9 ± 4.9 in late preterm and term infants, respectively (p 0.003).
Conclusions: Late preterm-born infants (33-36 WGA) had a higher rate of hospitalization for overall and RSV bronchiolitis during the first year of life compared to those born at term.
Keywords: Bronchiolitis; Late premature; Lower respiratory tract infections; RSV prophylaxis; Respiratory syncytial virus.
Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data.Am J Perinatol. 2023 Oct;40(14):1529-1536. doi: 10.1055/s-0041-1736581. Epub 2021 Oct 26. Am J Perinatol. 2023. PMID: 34704241 Free PMC article.
-
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4. J Perinatol. 2016. PMID: 27490190 Free PMC article.
-
Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.Pediatr Infect Dis J. 2000 Feb;19(2):138-43. doi: 10.1097/00006454-200002000-00012. Pediatr Infect Dis J. 2000. PMID: 10694001
-
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14. Lancet. 2024. PMID: 38367641
-
Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports.Ital J Pediatr. 2019 Nov 9;45(1):139. doi: 10.1186/s13052-019-0736-5. Ital J Pediatr. 2019. PMID: 31706338 Free PMC article.
Cited by
-
Impact of Palivizumab in Preventing Severe Acute Lower Respiratory Infection in Moderate-to-Late Preterm Infants: A Nationwide Cohort Study.J Korean Med Sci. 2024 Nov 11;39(43):e279. doi: 10.3346/jkms.2024.39.e279. J Korean Med Sci. 2024. PMID: 39536788 Free PMC article.
-
Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.Epidemiol Infect. 2022 Feb 2;150:e45. doi: 10.1017/S0950268822000152. Epidemiol Infect. 2022. PMID: 35105415 Free PMC article.
-
Respiratory, cardio-metabolic and neurodevelopmental long-term outcomes of moderate to late preterm birth: not just a near term-population. A follow-up study.Front Med (Lausanne). 2024 Aug 20;11:1381118. doi: 10.3389/fmed.2024.1381118. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39228801 Free PMC article.
-
Characteristics, Management, and Outcomes of Community-Acquired Pneumonia due to Respiratory Syncytial Virus: A Retrospective Study.Pulm Med. 2023 Mar 6;2023:4310418. doi: 10.1155/2023/4310418. eCollection 2023. Pulm Med. 2023. PMID: 36923702 Free PMC article.
-
Exploring the adoption of less restricted criteria for respiratory syncytial virus prophylaxis in late preterm infants: insights from a retrospective analysis.Front Pediatr. 2023 Jun 8;11:1154518. doi: 10.3389/fped.2023.1154518. eCollection 2023. Front Pediatr. 2023. PMID: 37360357 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical